Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Chesov, Dumitru ^a,b   Lange, Christoph ^b,c,d,e   Daduna, Franziska ^b,c   Crudu, Valeriu ^f   Preyer, Rosemarie ^g   Ernst, Martin ^b   Kalsdorf, Barbara ^b,c  

^a STATE UNIVERSITY OF MEDICINE AND PHARMACY NICOLAE TESTEMITANU   (Moldova)

^b RESEARCH CENTER BORSTEL   (Germany)

^c German Center for Infection Research   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

^e KAROLINSKA INSTITUTE   (Sweden)

^f Phthisiopneumology Institute Chiril Draganiuc   (Moldova)

^g Autoimmun Diagnostika GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; INTERLEUKIN 2; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSPOT ASSAY; ENZYME LINKED IMMUNOSPOT INTERFERON GAMMA RELEASE ASSAY; EX VIVO STUDY; FEMALE; FLUORESCENCE ANALYSIS; FLUORESCENCE LINKED IMMUNOSPOT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; INFECTION; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; CASE CONTROL STUDY; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROCEDURES; SECRETION (PROCESS); TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; INTERLEUKIN-2; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84925645309     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120006     Document Type: Article

References (26)

1. World Health Organization. Global Tuberculosis Report. Geneva: World Health Organization; 2014.
2. Stop TB Partnership and World Health Organization. Global Plan to Stop TB 2006-2015. Geneva: World Health Organization; 2006.
3. Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J. 2014; 44: 23-63. doi: 10.1183/09031936.00188313 PMID: 24659544
4. LoBue PA, Castro KG. Is it time to replace the tuberculin skin test with a blood test? JAMA. 2012; 308: 241-242. doi: 10.1001/jama.2012.7511 PMID: 22797639
5. Chegou NN, Heyckendorf J, Walzl G, Lange C, Ruhwald M. Beyond the IFN-gamma horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis. Eur Respir J. 2014; 43: 1472-1486. doi: 10.1183/09031936.00151413 PMID: 24311770
6. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004; 4: 761-776. PMID: 15567126
7. Pai M, Joshi R, Bandyopadhyay M, Narang P, Dogra S, Taksande B, et al. Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection. 2007; 35: 98-103. PMID: 17401714
8. Millington KA, Innes JA, Hackforth S, Hinks TS, Deeks JJ, Dosanjh DP, et al. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol. 2007; 178: 5217-5226. PMID: 17404305
9. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol. 2009; 39: 723-729. doi: 10.1002/eji.200838693 PMID: 19224636
10. Harari A, Rozot V, Bellutti Enders F, Perreau M, Stalder JM, Nicod LP, et al. Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med. 2011; 17: 372-376. doi: 10.1038/nm.2299 PMID: 21336285
11. Essone PN, Kalsdorf B, Chegou NN, Loxton AG, Kriel M, Preyer R, et al. Bifunctional T-cell-derived cytokines for the diagnosis of tuberculosis and treatment monitoring. Respiration. 2014; 88: 251-261. doi: 10.1159/000365816 PMID: 25171202
12. Casey R, Blumenkrantz D, Millington K, Montamat-Sicotte D, Kon OM, Wickremasinghe M, et al. Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLOS One. 2010; 5: e15619. doi: 10.1371/journal.pone.0015619 PMID: 21179481
13. Sester U, Fousse M, Dirks J, Mack U, Prasse A, Singh M, et al. Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states. PLOS One. 2011; 6: e17813. doi: 10.1371/journal.pone.0017813 PMID: 21423578
14. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009; 33: 956-973. doi: 10.1183/09031936.00120908 PMID: 19407047
15. T-SPOT.TB package insert. Oxford Immunotec Limited. 2013. Available: http://www.oxfordimmunotec.com/international/wp-content/uploads/sites/3/PI-TB-IVD-UK-V2.pdf Accessed 2014 Oct 03.
16. Jafari C, Thijsen S, Sotgiu G, Goletti D, Domínguez Benítez JA, Losi M, et al. Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trials group study. Am J Respir Crit Care Med. 2009; 180: 666-673. doi: 10.1164/rccm.200904-0557OC PMID: 19590020
17. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999; 8: 135-160. PMID: 10501650
18. Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, Pinnetti C, Sampaolesi A, et al. Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients. J Infect. 2014 Dec; 69(6): 533-45. doi: 10.1016/j.jinf.2014.06.009 PMID: 24975174
19. Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, Titone L, et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol. 2010; 40: 2211-2220. doi: 10.1002/eji.201040455 PMID: 20540114
20. Sargentini V, Mariotti S, Carrara S, Gagliardi MC, Teloni R, Goletti D, et al. Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis. 2009; 9: 99. doi: 10.1186/1471-2334-9-99 PMID: 19549330
21. Nemeth J, Winkler HM, Karlhofer F, Selenko-Gebauer N, Graninger W, Winkler S. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis. Eur Cytokine Netw. 2010; 21: 34-39. doi: 10.1684/ecn.2009.0182 PMID: 20146988
22. Rovina N, Panagiotou M, Pontikis K, Kyriakopoulou M, Koulouris NG, Koutsoukou A. Immune response to mycobacterial infection: lessons from flow cytometry. Clin Dev Immunol. 2013; 2013: 464039. doi: 10.1155/2013/464039 PMID: 24376464
23. Prezzemolo T, Guggino G, La Manna MP, Di Liberto D, Dieli F, Caccamo N. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis. Front Immunol. 2014; 5: 180. doi: 10.3389/fimmu.2014.00180 PMID: 24795723
24. Biselli R, Mariotti S, Sargentini V, Sauzullo I, Lastilla M, Mengoni F, et al. Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. Clin Microbiol Infect 2010; 16: 1282-1284. doi: 10.1111/j.1469-0691.2009.03104.x PMID: 19886902
25. Marin ND, Paris SC, Rojas M, Garcia LF. Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB. Tuberculosis (Edinb). 2013; 93: 155-166. doi: 10.1016/j.tube.2012.12.002 PMID: 23332142
26. Day CL, Abrahams DA, Lerumo L, Janse van Rensburg E, Stone L, O'Rie T, et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol. 2011; 187: 2222-2232. doi: 10.4049/jimmunol.1101122 PMID: 21775682